Your Health, We Care
1. Elevated liver enzymes and drug-induced liver injury.
2. Gastrointestinal disorders.
3. Embryo-fetal toxicity.
4. Arterial thromboembolic events.
5. Bleeding risk.
6. Gastrointestinal perforation.
7. Nephrotic-range proteinuria.
FDA，2024.10
In 2019, nintedanib became the first therapy approved by the FDA to slow the rate of lung function d···【more】
Recommended：92026-03-02
In 2019, nintedanib became the first therapy approved by the FDA to slow the rate of lung function decline in adults with SSc-ILD.What side effects may occur with nintedanib?The fo···【more】
Article source：Lucius LaosRelease date：2026-02-03Recommended：9
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
